Inhibition of Bcl-2 and Bcl-xL overcomes the resistance to the third-generation EGFR tyrosine kinase inhibitor osimertinib in non-small cell lung cancerYingjie Lu(Huadong Hospital), Zhenghong Zhu(Fudan University)Molecular Medicine ReportsNovember 12, 202010.3892/mmr.2020.11686Cited by 29SaveCiteExport RISWatch citationsRelated PapersGestational PM2.5 exposure may increase the risk of small for gestational age through maternal blood pressure and hemoglobin: A mediation analysis based on a prospective cohort in China, 2014–2018|Ecotoxicology and Environmental Safety|2022|12